Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Pain Management

PUBLISHER: Acute Market Reports | PRODUCT CODE: 1743253

Cover Image

PUBLISHER: Acute Market Reports | PRODUCT CODE: 1743253

Post-operative Pain Therapeutics Market - Growth, Future Prospects and Competitive Analysis, 2025 - 2033

PUBLISHED:
PAGES: 185 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Multi User License)
USD 6500
PDF (Enterprise License)
USD 9000

Add to Cart

Description

Table of Contents

List of Tables

The post-operative pain therapeutics market encompasses the segment of healthcare that focuses on the management and treatment of pain following surgical procedures. This market includes pharmaceuticals such as opioids, non-steroidal anti-inflammatory drugs (NSAIDs), local anesthetics, and other pain relief medications that are used to alleviate acute pain in the post-surgical setting. The purpose of these therapies is not only to improve patient comfort but also to facilitate quicker recovery, prevent complications, and reduce the duration of hospital stays. The global post-operative pain therapeutics market is projected to grow at a compound annual growth rate (CAGR) of 5.5% from 2025 to 2033, driven by the increasing number of surgical procedures performed worldwide and the growing recognition of the importance of effective pain management. As medical practices continue to advance, there is a higher incidence of surgeries, which subsequently increases the demand for effective post-operative pain solutions. The market is also influenced by the development of new drugs and delivery systems that offer longer pain relief with fewer side effects.

Increasing Surgical Procedures Globally

The primary driver of the post-operative pain therapeutics market is the increasing number of surgical procedures being performed worldwide. This rise is largely due to the growing global population and the higher prevalence of conditions that require surgical intervention, such as cardiovascular diseases, orthopedic conditions, and cancers. Additionally, advancements in medical technology have made surgeries safer and more accessible, contributing to the rise in surgical interventions. As the number of surgeries increases, so does the demand for effective post-operative pain management solutions, driving substantial growth in this market sector. The ongoing development of minimally invasive surgical techniques, which still require post-operative pain management but promise quicker recovery, further bolsters this demand.

Advancements in Drug Development and Pain Management Techniques

There is a significant opportunity in the development of new pharmacological formulations and novel drug delivery systems for post-operative pain management. Innovations such as extended-release formulations and targeted drug delivery systems are set to enhance the efficacy and safety of post-operative pain therapies, reducing side effects associated with traditional pain management methods like opioids. This innovation addresses a critical market need for more effective and safer pain management solutions, presenting a substantial growth opportunity as healthcare providers continue to seek better ways to manage patient pain post-surgery.

Opioid Crisis and Regulatory Challenges

The opioid crisis has become a significant restraint in the post-operative pain therapeutics market, particularly in regions like North America. The high addiction and overdose rates associated with opioid use have led to stringent regulatory measures, significantly affecting the prescription of opioid medications. These regulatory challenges compel healthcare providers to seek alternative therapies, which may not always be as effective, creating a gap in adequate patient pain management and impacting the market growth negatively.

Balancing Efficacy with Patient Safety

A major challenge facing the post-operative pain therapeutics market is balancing drug efficacy with patient safety. The need to provide effective pain relief while minimizing side effects and avoiding long-term dependency issues poses a complex challenge for drug developers and healthcare providers. This balance is critical in maintaining patient quality of life and ensuring compliance with evolving regulatory guidelines, which increasingly favor non-opioid alternatives and demand rigorous proof of safety and efficacy for new pain management drugs.

Market Segmentation by Drug Class

The post-operative pain therapeutics market is segmented into various drug classes, including Opioids, NSAIDs, Local Anesthetics, Tricyclic Antidepressants, Antiepileptic drugs, and Others. Opioids have historically dominated the market in terms of revenue due to their potent pain-relieving properties and widespread usage in severe post-operative pain management. However, due to increasing regulatory scrutiny and the growing opioid abuse epidemic, their market share is experiencing constraints. Meanwhile, Local Anesthetics are projected to register the highest CAGR. This growth is attributed to their efficacy in managing pain with a lower risk profile compared to opioids. Local anesthetics are increasingly preferred in both surgical settings and outpatient procedures, promoting their rapid adoption. Additionally, advancements in formulations that extend the duration of pain relief further drive their popularity, positioning them as a safer alternative in post-operative pain management with significant growth potential.

Market Segmentation by Route of Administration

The post-operative pain therapeutics market is also segmented by the route of administration, including Oral, Intravenous, Intramuscular, and Others. Oral administration leads in revenue generation due to the convenience, patient compliance, and widespread availability of oral pain management medications. This segment benefits from ongoing developments in drug formulations that enhance the efficacy and duration of relief, suitable for managing pain in various post-operative scenarios. Intravenous (IV) administration is expected to exhibit the highest CAGR, driven by its ability to provide immediate pain relief, which is crucial in managing severe post-operative pain. IV pain management is essential in hospital settings, particularly immediately following surgery, offering precise dosing and immediate onset of action, which are critical for effective pain management in acute care scenarios. The growth in surgical procedures and the need for immediate post-operative pain relief contribute to the expanding use of IV administration.

Geographic Trends

The post-operative pain therapeutics market exhibits distinct geographic trends with North America historically leading in revenue generation due to its well-established healthcare infrastructure, high healthcare spending, and stringent regulatory guidelines that drive the adoption of advanced therapeutic solutions. In 2024, North America was the largest revenue contributor, supported by an ongoing opioid crisis which prompted the rapid adoption of alternative pain management therapies. However, Asia Pacific is expected to exhibit the highest CAGR from 2025 to 2033. This surge is driven by increasing surgical procedures, rising healthcare expenditures, and growing awareness about effective pain management in emerging economies like China and India. These regions are rapidly adopting modern healthcare practices, and their governments are implementing more stringent post-operative pain management protocols, significantly contributing to market growth.

Competitive Trends

In 2024, the competitive landscape of the post-operative pain therapeutics market was prominently shaped by key players such as Mallinckrodt Pharmaceuticals, Pfizer, Inc., Novartis AG, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Camurus AB, Bayer AG, Pacira BioSciences, Inc., and Trevena, Inc. These companies held significant market shares, primarily due to their robust drug portfolios and strong distribution networks. From 2025 to 2033, these players are expected to focus on strategic collaborations, acquisitions, and the development of new, innovative products to expand their market presence. For example, companies are investing in the development of non-opioid pain relievers and long-acting local anesthetics to mitigate the risks associated with opioid use. Additionally, these firms are anticipated to enhance their geographic footprint, particularly in high-growth regions such as Asia Pacific, by leveraging local partnerships and tailoring their drug offerings to meet regional regulatory and clinical requirements. The ongoing innovation in drug formulations and administration technologies is also expected to play a crucial role in maintaining competitive advantages and addressing the diverse needs of the post-operative patient population globally.

Historical & Forecast Period

This study report represents an analysis of each segment from 2023 to 2033 considering 2024 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2025 to 2033.

The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Post-operative Pain Therapeutics market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users & consumption volume, price, and value.

Geographical revenues generated by countries considered in the report

Micro and macro environment factors that are currently influencing the Post-operative Pain Therapeutics market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.

Market Segmentation

  • Drug Class
  • Opioids
  • NSAIDs
  • Local Anesthetics
  • Tricyclic Antidepressants
  • Antiepileptic drugs
  • Others
  • Route of Administration
  • Oral
  • Intravenous
  • Intramuscular
  • Others
  • Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others
  • Region Segment (2023-2033; US$ Million)
  • North America
  • U.S.
  • Canada
  • Rest of North America
  • UK and European Union
  • UK
  • Germany
  • Spain
  • Italy
  • France
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East and Africa
  • GCC
  • Africa
  • Rest of Middle East and Africa

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Post-operative Pain Therapeutics market?
  • What are the key investment pockets concerning product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2033.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Post-operative Pain Therapeutics market?
  • Which is the largest regional market for Post-operative Pain Therapeutics market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Post-operative Pain Therapeutics market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Post-operative Pain Therapeutics market worldwide?
Show more
Product Code: 141407-04-25

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Post-operative Pain Therapeutics Market
  • 2.2. Global Post-operative Pain Therapeutics Market, By Drug Class, 2024 (US$ Million)
  • 2.3. Global Post-operative Pain Therapeutics Market, By Route of Administration, 2024 (US$ Million)
  • 2.4. Global Post-operative Pain Therapeutics Market, By Distribution Channel, 2024 (US$ Million)
  • 2.5. Global Post-operative Pain Therapeutics Market, By Geography, 2024 (US$ Million)
  • 2.6. Attractive Investment Proposition by Geography, 2024

3. Post-operative Pain Therapeutics Market: Competitive Analysis

  • 3.1. Market Positioning of Key Post-operative Pain Therapeutics Market Vendors
  • 3.2. Strategies Adopted by Post-operative Pain Therapeutics Market Vendors

4. Post-operative Pain Therapeutics Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Post-operative Pain Therapeutics Market Value, 2023 - 2033, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. Porter's Five Force Model
    • 4.5.1. Supplier Power
    • 4.5.2. Buyer Power
    • 4.5.3. Threat Of Substitutes
    • 4.5.4. Threat Of New Entrants
    • 4.5.5. Competitive Rivalry
  • 4.6. PESTEL Analysis
    • 4.6.1. Political Landscape
    • 4.6.2. Economic Landscape
    • 4.6.3. Technology Landscape
    • 4.6.4. Legal Landscape
    • 4.6.5. Social Landscape

5. Post-operative Pain Therapeutics Market: By Drug Class, 2023-2033, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2024 Versus 2033
  • 5.3. Market Segmentation
    • 5.3.1. Opioids
    • 5.3.2. NSAIDs
    • 5.3.3. Local Anesthetics
    • 5.3.4. Tricyclic Antidepressants
    • 5.3.5. Antiepileptic drugs
    • 5.3.6. Others

6. Post-operative Pain Therapeutics Market: By Route of Administration, 2023-2033, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2024 Versus 2033
  • 6.3. Market Segmentation
    • 6.3.1. Oral
    • 6.3.2. Intravenous
    • 6.3.3. Intramuscular
    • 6.3.4. Others

7. Post-operative Pain Therapeutics Market: By Distribution Channel, 2023-2033, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2024 Versus 2033
  • 7.3. Market Segmentation
    • 7.3.1. Hospital Pharmacies
    • 7.3.2. Retail Pharmacies
    • 7.3.3. Online Pharmacies
    • 7.3.4. Others

8. North America Post-operative Pain Therapeutics Market, 2023-2033, USD (Million)

  • 8.1. Market Overview
  • 8.2. Post-operative Pain Therapeutics Market: By Drug Class, 2023-2033, USD (Million)
  • 8.3. Post-operative Pain Therapeutics Market: By Route of Administration, 2023-2033, USD (Million)
  • 8.4. Post-operative Pain Therapeutics Market: By Distribution Channel, 2023-2033, USD (Million)
  • 8.5. Post-operative Pain Therapeutics Market: By Region, 2023-2033, USD (Million)
    • 8.5.1. North America
      • 8.5.1.1. U.S.
        • 8.5.1.1.1. Post-operative Pain Therapeutics Market: By Drug Class, 2023-2033, USD (Million)
        • 8.5.1.1.2. Post-operative Pain Therapeutics Market: By Route of Administration, 2023-2033, USD (Million)
        • 8.5.1.1.3. Post-operative Pain Therapeutics Market: By Distribution Channel, 2023-2033, USD (Million)
      • 8.5.1.2. Canada
        • 8.5.1.2.1. Post-operative Pain Therapeutics Market: By Drug Class, 2023-2033, USD (Million)
        • 8.5.1.2.2. Post-operative Pain Therapeutics Market: By Route of Administration, 2023-2033, USD (Million)
        • 8.5.1.2.3. Post-operative Pain Therapeutics Market: By Distribution Channel, 2023-2033, USD (Million)
      • 8.5.1.3. Rest of North America
        • 8.5.1.3.1. Post-operative Pain Therapeutics Market: By Drug Class, 2023-2033, USD (Million)
        • 8.5.1.3.2. Post-operative Pain Therapeutics Market: By Route of Administration, 2023-2033, USD (Million)
        • 8.5.1.3.3. Post-operative Pain Therapeutics Market: By Distribution Channel, 2023-2033, USD (Million)

9. UK and European Union Post-operative Pain Therapeutics Market, 2023-2033, USD (Million)

  • 9.1. Market Overview
  • 9.2. Post-operative Pain Therapeutics Market: By Drug Class, 2023-2033, USD (Million)
  • 9.3. Post-operative Pain Therapeutics Market: By Route of Administration, 2023-2033, USD (Million)
  • 9.4. Post-operative Pain Therapeutics Market: By Distribution Channel, 2023-2033, USD (Million)
  • 9.5. Post-operative Pain Therapeutics Market: By Region, 2023-2033, USD (Million)
    • 9.5.1. UK and European Union
      • 9.5.1.1. UK
        • 9.5.1.1.1. Post-operative Pain Therapeutics Market: By Drug Class, 2023-2033, USD (Million)
        • 9.5.1.1.2. Post-operative Pain Therapeutics Market: By Route of Administration, 2023-2033, USD (Million)
        • 9.5.1.1.3. Post-operative Pain Therapeutics Market: By Distribution Channel, 2023-2033, USD (Million)
      • 9.5.1.2. Germany
        • 9.5.1.2.1. Post-operative Pain Therapeutics Market: By Drug Class, 2023-2033, USD (Million)
        • 9.5.1.2.2. Post-operative Pain Therapeutics Market: By Route of Administration, 2023-2033, USD (Million)
        • 9.5.1.2.3. Post-operative Pain Therapeutics Market: By Distribution Channel, 2023-2033, USD (Million)
      • 9.5.1.3. Spain
        • 9.5.1.3.1. Post-operative Pain Therapeutics Market: By Drug Class, 2023-2033, USD (Million)
        • 9.5.1.3.2. Post-operative Pain Therapeutics Market: By Route of Administration, 2023-2033, USD (Million)
        • 9.5.1.3.3. Post-operative Pain Therapeutics Market: By Distribution Channel, 2023-2033, USD (Million)
      • 9.5.1.4. Italy
        • 9.5.1.4.1. Post-operative Pain Therapeutics Market: By Drug Class, 2023-2033, USD (Million)
        • 9.5.1.4.2. Post-operative Pain Therapeutics Market: By Route of Administration, 2023-2033, USD (Million)
        • 9.5.1.4.3. Post-operative Pain Therapeutics Market: By Distribution Channel, 2023-2033, USD (Million)
      • 9.5.1.5. France
        • 9.5.1.5.1. Post-operative Pain Therapeutics Market: By Drug Class, 2023-2033, USD (Million)
        • 9.5.1.5.2. Post-operative Pain Therapeutics Market: By Route of Administration, 2023-2033, USD (Million)
        • 9.5.1.5.3. Post-operative Pain Therapeutics Market: By Distribution Channel, 2023-2033, USD (Million)
      • 9.5.1.6. Rest of Europe
        • 9.5.1.6.1. Post-operative Pain Therapeutics Market: By Drug Class, 2023-2033, USD (Million)
        • 9.5.1.6.2. Post-operative Pain Therapeutics Market: By Route of Administration, 2023-2033, USD (Million)
        • 9.5.1.6.3. Post-operative Pain Therapeutics Market: By Distribution Channel, 2023-2033, USD (Million)

10. Asia Pacific Post-operative Pain Therapeutics Market, 2023-2033, USD (Million)

  • 10.1. Market Overview
  • 10.2. Post-operative Pain Therapeutics Market: By Drug Class, 2023-2033, USD (Million)
  • 10.3. Post-operative Pain Therapeutics Market: By Route of Administration, 2023-2033, USD (Million)
  • 10.4. Post-operative Pain Therapeutics Market: By Distribution Channel, 2023-2033, USD (Million)
  • 10.5. Post-operative Pain Therapeutics Market: By Region, 2023-2033, USD (Million)
    • 10.5.1. Asia Pacific
      • 10.5.1.1. China
        • 10.5.1.1.1. Post-operative Pain Therapeutics Market: By Drug Class, 2023-2033, USD (Million)
        • 10.5.1.1.2. Post-operative Pain Therapeutics Market: By Route of Administration, 2023-2033, USD (Million)
        • 10.5.1.1.3. Post-operative Pain Therapeutics Market: By Distribution Channel, 2023-2033, USD (Million)
      • 10.5.1.2. Japan
        • 10.5.1.2.1. Post-operative Pain Therapeutics Market: By Drug Class, 2023-2033, USD (Million)
        • 10.5.1.2.2. Post-operative Pain Therapeutics Market: By Route of Administration, 2023-2033, USD (Million)
        • 10.5.1.2.3. Post-operative Pain Therapeutics Market: By Distribution Channel, 2023-2033, USD (Million)
      • 10.5.1.3. India
        • 10.5.1.3.1. Post-operative Pain Therapeutics Market: By Drug Class, 2023-2033, USD (Million)
        • 10.5.1.3.2. Post-operative Pain Therapeutics Market: By Route of Administration, 2023-2033, USD (Million)
        • 10.5.1.3.3. Post-operative Pain Therapeutics Market: By Distribution Channel, 2023-2033, USD (Million)
      • 10.5.1.4. Australia
        • 10.5.1.4.1. Post-operative Pain Therapeutics Market: By Drug Class, 2023-2033, USD (Million)
        • 10.5.1.4.2. Post-operative Pain Therapeutics Market: By Route of Administration, 2023-2033, USD (Million)
        • 10.5.1.4.3. Post-operative Pain Therapeutics Market: By Distribution Channel, 2023-2033, USD (Million)
      • 10.5.1.5. South Korea
        • 10.5.1.5.1. Post-operative Pain Therapeutics Market: By Drug Class, 2023-2033, USD (Million)
        • 10.5.1.5.2. Post-operative Pain Therapeutics Market: By Route of Administration, 2023-2033, USD (Million)
        • 10.5.1.5.3. Post-operative Pain Therapeutics Market: By Distribution Channel, 2023-2033, USD (Million)
      • 10.5.1.6. Rest of Asia Pacific
        • 10.5.1.6.1. Post-operative Pain Therapeutics Market: By Drug Class, 2023-2033, USD (Million)
        • 10.5.1.6.2. Post-operative Pain Therapeutics Market: By Route of Administration, 2023-2033, USD (Million)
        • 10.5.1.6.3. Post-operative Pain Therapeutics Market: By Distribution Channel, 2023-2033, USD (Million)

11. Latin America Post-operative Pain Therapeutics Market, 2023-2033, USD (Million)

  • 11.1. Market Overview
  • 11.2. Post-operative Pain Therapeutics Market: By Drug Class, 2023-2033, USD (Million)
  • 11.3. Post-operative Pain Therapeutics Market: By Route of Administration, 2023-2033, USD (Million)
  • 11.4. Post-operative Pain Therapeutics Market: By Distribution Channel, 2023-2033, USD (Million)
  • 11.5. Post-operative Pain Therapeutics Market: By Region, 2023-2033, USD (Million)
    • 11.5.1. Latin America
      • 11.5.1.1. Brazil
        • 11.5.1.1.1. Post-operative Pain Therapeutics Market: By Drug Class, 2023-2033, USD (Million)
        • 11.5.1.1.2. Post-operative Pain Therapeutics Market: By Route of Administration, 2023-2033, USD (Million)
        • 11.5.1.1.3. Post-operative Pain Therapeutics Market: By Distribution Channel, 2023-2033, USD (Million)
      • 11.5.1.2. Mexico
        • 11.5.1.2.1. Post-operative Pain Therapeutics Market: By Drug Class, 2023-2033, USD (Million)
        • 11.5.1.2.2. Post-operative Pain Therapeutics Market: By Route of Administration, 2023-2033, USD (Million)
        • 11.5.1.2.3. Post-operative Pain Therapeutics Market: By Distribution Channel, 2023-2033, USD (Million)
      • 11.5.1.3. Rest of Latin America
        • 11.5.1.3.1. Post-operative Pain Therapeutics Market: By Drug Class, 2023-2033, USD (Million)
        • 11.5.1.3.2. Post-operative Pain Therapeutics Market: By Route of Administration, 2023-2033, USD (Million)
        • 11.5.1.3.3. Post-operative Pain Therapeutics Market: By Distribution Channel, 2023-2033, USD (Million)

12. Middle East and Africa Post-operative Pain Therapeutics Market, 2023-2033, USD (Million)

  • 12.1. Market Overview
  • 12.2. Post-operative Pain Therapeutics Market: By Drug Class, 2023-2033, USD (Million)
  • 12.3. Post-operative Pain Therapeutics Market: By Route of Administration, 2023-2033, USD (Million)
  • 12.4. Post-operative Pain Therapeutics Market: By Distribution Channel, 2023-2033, USD (Million)
  • 12.5. Post-operative Pain Therapeutics Market: By Region, 2023-2033, USD (Million)
    • 12.5.1. Middle East and Africa
      • 12.5.1.1. GCC
        • 12.5.1.1.1. Post-operative Pain Therapeutics Market: By Drug Class, 2023-2033, USD (Million)
        • 12.5.1.1.2. Post-operative Pain Therapeutics Market: By Route of Administration, 2023-2033, USD (Million)
        • 12.5.1.1.3. Post-operative Pain Therapeutics Market: By Distribution Channel, 2023-2033, USD (Million)
      • 12.5.1.2. Africa
        • 12.5.1.2.1. Post-operative Pain Therapeutics Market: By Drug Class, 2023-2033, USD (Million)
        • 12.5.1.2.2. Post-operative Pain Therapeutics Market: By Route of Administration, 2023-2033, USD (Million)
        • 12.5.1.2.3. Post-operative Pain Therapeutics Market: By Distribution Channel, 2023-2033, USD (Million)
      • 12.5.1.3. Rest of Middle East and Africa
        • 12.5.1.3.1. Post-operative Pain Therapeutics Market: By Drug Class, 2023-2033, USD (Million)
        • 12.5.1.3.2. Post-operative Pain Therapeutics Market: By Route of Administration, 2023-2033, USD (Million)
        • 12.5.1.3.3. Post-operative Pain Therapeutics Market: By Distribution Channel, 2023-2033, USD (Million)

13. Company Profile

  • 13.1. Mallinckrodt Pharmaceuticals

(Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)

  • 13.2. Pfizer, Inc.
  • 13.3. Novartis AG
  • 13.4. Eli Lilly and Company
  • 13.5. Teva Pharmaceutical Industries Ltd.
  • 13.6. Camurus AB
  • 13.7. Bayer AG
  • 13.8. Pacira BioSciences, Inc.
  • 13.9. Trevena, Inc.
Show more
Product Code: 141407-04-25

List of Tables

  • TABLE 1 Global Post-operative Pain Therapeutics Market By Drug Class, 2023-2033, USD (Million)
  • TABLE 2 Global Post-operative Pain Therapeutics Market By Route of Administration, 2023-2033, USD (Million)
  • TABLE 3 Global Post-operative Pain Therapeutics Market By Distribution Channel, 2023-2033, USD (Million)
  • TABLE 4 North America Post-operative Pain Therapeutics Market By Drug Class, 2023-2033, USD (Million)
  • TABLE 5 North America Post-operative Pain Therapeutics Market By Route of Administration, 2023-2033, USD (Million)
  • TABLE 6 North America Post-operative Pain Therapeutics Market By Distribution Channel, 2023-2033, USD (Million)
  • TABLE 7 U.S. Post-operative Pain Therapeutics Market By Drug Class, 2023-2033, USD (Million)
  • TABLE 8 U.S. Post-operative Pain Therapeutics Market By Route of Administration, 2023-2033, USD (Million)
  • TABLE 9 U.S. Post-operative Pain Therapeutics Market By Distribution Channel, 2023-2033, USD (Million)
  • TABLE 10 Canada Post-operative Pain Therapeutics Market By Drug Class, 2023-2033, USD (Million)
  • TABLE 11 Canada Post-operative Pain Therapeutics Market By Route of Administration, 2023-2033, USD (Million)
  • TABLE 12 Canada Post-operative Pain Therapeutics Market By Distribution Channel, 2023-2033, USD (Million)
  • TABLE 13 Rest of North America Post-operative Pain Therapeutics Market By Drug Class, 2023-2033, USD (Million)
  • TABLE 14 Rest of North America Post-operative Pain Therapeutics Market By Route of Administration, 2023-2033, USD (Million)
  • TABLE 15 Rest of North America Post-operative Pain Therapeutics Market By Distribution Channel, 2023-2033, USD (Million)
  • TABLE 16 UK and European Union Post-operative Pain Therapeutics Market By Drug Class, 2023-2033, USD (Million)
  • TABLE 17 UK and European Union Post-operative Pain Therapeutics Market By Route of Administration, 2023-2033, USD (Million)
  • TABLE 18 UK and European Union Post-operative Pain Therapeutics Market By Distribution Channel, 2023-2033, USD (Million)
  • TABLE 19 UK Post-operative Pain Therapeutics Market By Drug Class, 2023-2033, USD (Million)
  • TABLE 20 UK Post-operative Pain Therapeutics Market By Route of Administration, 2023-2033, USD (Million)
  • TABLE 21 UK Post-operative Pain Therapeutics Market By Distribution Channel, 2023-2033, USD (Million)
  • TABLE 22 Germany Post-operative Pain Therapeutics Market By Drug Class, 2023-2033, USD (Million)
  • TABLE 23 Germany Post-operative Pain Therapeutics Market By Route of Administration, 2023-2033, USD (Million)
  • TABLE 24 Germany Post-operative Pain Therapeutics Market By Distribution Channel, 2023-2033, USD (Million)
  • TABLE 25 Spain Post-operative Pain Therapeutics Market By Drug Class, 2023-2033, USD (Million)
  • TABLE 26 Spain Post-operative Pain Therapeutics Market By Route of Administration, 2023-2033, USD (Million)
  • TABLE 27 Spain Post-operative Pain Therapeutics Market By Distribution Channel, 2023-2033, USD (Million)
  • TABLE 28 Italy Post-operative Pain Therapeutics Market By Drug Class, 2023-2033, USD (Million)
  • TABLE 29 Italy Post-operative Pain Therapeutics Market By Route of Administration, 2023-2033, USD (Million)
  • TABLE 30 Italy Post-operative Pain Therapeutics Market By Distribution Channel, 2023-2033, USD (Million)
  • TABLE 31 France Post-operative Pain Therapeutics Market By Drug Class, 2023-2033, USD (Million)
  • TABLE 32 France Post-operative Pain Therapeutics Market By Route of Administration, 2023-2033, USD (Million)
  • TABLE 33 France Post-operative Pain Therapeutics Market By Distribution Channel, 2023-2033, USD (Million)
  • TABLE 34 Rest of Europe Post-operative Pain Therapeutics Market By Drug Class, 2023-2033, USD (Million)
  • TABLE 35 Rest of Europe Post-operative Pain Therapeutics Market By Route of Administration, 2023-2033, USD (Million)
  • TABLE 36 Rest of Europe Post-operative Pain Therapeutics Market By Distribution Channel, 2023-2033, USD (Million)
  • TABLE 37 Asia Post-operative Pain Therapeutics Market By Drug Class, 2023-2033, USD (Million)
  • TABLE 38 Asia Post-operative Pain Therapeutics Market By Route of Administration, 2023-2033, USD (Million)
  • TABLE 39 Asia Post-operative Pain Therapeutics Market By Distribution Channel, 2023-2033, USD (Million)
  • TABLE 40 China Post-operative Pain Therapeutics Market By Drug Class, 2023-2033, USD (Million)
  • TABLE 41 China Post-operative Pain Therapeutics Market By Route of Administration, 2023-2033, USD (Million)
  • TABLE 42 China Post-operative Pain Therapeutics Market By Distribution Channel, 2023-2033, USD (Million)
  • TABLE 43 Japan Post-operative Pain Therapeutics Market By Drug Class, 2023-2033, USD (Million)
  • TABLE 44 Japan Post-operative Pain Therapeutics Market By Route of Administration, 2023-2033, USD (Million)
  • TABLE 45 Japan Post-operative Pain Therapeutics Market By Distribution Channel, 2023-2033, USD (Million)
  • TABLE 46 India Post-operative Pain Therapeutics Market By Drug Class, 2023-2033, USD (Million)
  • TABLE 47 India Post-operative Pain Therapeutics Market By Route of Administration, 2023-2033, USD (Million)
  • TABLE 48 India Post-operative Pain Therapeutics Market By Distribution Channel, 2023-2033, USD (Million)
  • TABLE 49 Australia Post-operative Pain Therapeutics Market By Drug Class, 2023-2033, USD (Million)
  • TABLE 50 Australia Post-operative Pain Therapeutics Market By Route of Administration, 2023-2033, USD (Million)
  • TABLE 51 Australia Post-operative Pain Therapeutics Market By Distribution Channel, 2023-2033, USD (Million)
  • TABLE 52 South Korea Post-operative Pain Therapeutics Market By Drug Class, 2023-2033, USD (Million)
  • TABLE 53 South Korea Post-operative Pain Therapeutics Market By Route of Administration, 2023-2033, USD (Million)
  • TABLE 54 South Korea Post-operative Pain Therapeutics Market By Distribution Channel, 2023-2033, USD (Million)
  • TABLE 55 Latin America Post-operative Pain Therapeutics Market By Drug Class, 2023-2033, USD (Million)
  • TABLE 56 Latin America Post-operative Pain Therapeutics Market By Route of Administration, 2023-2033, USD (Million)
  • TABLE 57 Latin America Post-operative Pain Therapeutics Market By Distribution Channel, 2023-2033, USD (Million)
  • TABLE 58 Brazil Post-operative Pain Therapeutics Market By Drug Class, 2023-2033, USD (Million)
  • TABLE 59 Brazil Post-operative Pain Therapeutics Market By Route of Administration, 2023-2033, USD (Million)
  • TABLE 60 Brazil Post-operative Pain Therapeutics Market By Distribution Channel, 2023-2033, USD (Million)
  • TABLE 61 Mexico Post-operative Pain Therapeutics Market By Drug Class, 2023-2033, USD (Million)
  • TABLE 62 Mexico Post-operative Pain Therapeutics Market By Route of Administration, 2023-2033, USD (Million)
  • TABLE 63 Mexico Post-operative Pain Therapeutics Market By Distribution Channel, 2023-2033, USD (Million)
  • TABLE 64 Rest of Latin America Post-operative Pain Therapeutics Market By Drug Class, 2023-2033, USD (Million)
  • TABLE 65 Rest of Latin America Post-operative Pain Therapeutics Market By Route of Administration, 2023-2033, USD (Million)
  • TABLE 66 Rest of Latin America Post-operative Pain Therapeutics Market By Distribution Channel, 2023-2033, USD (Million)
  • TABLE 67 Middle East and Africa Post-operative Pain Therapeutics Market By Drug Class, 2023-2033, USD (Million)
  • TABLE 68 Middle East and Africa Post-operative Pain Therapeutics Market By Route of Administration, 2023-2033, USD (Million)
  • TABLE 69 Middle East and Africa Post-operative Pain Therapeutics Market By Distribution Channel, 2023-2033, USD (Million)
  • TABLE 70 GCC Post-operative Pain Therapeutics Market By Drug Class, 2023-2033, USD (Million)
  • TABLE 71 GCC Post-operative Pain Therapeutics Market By Route of Administration, 2023-2033, USD (Million)
  • TABLE 72 GCC Post-operative Pain Therapeutics Market By Distribution Channel, 2023-2033, USD (Million)
  • TABLE 73 Africa Post-operative Pain Therapeutics Market By Drug Class, 2023-2033, USD (Million)
  • TABLE 74 Africa Post-operative Pain Therapeutics Market By Route of Administration, 2023-2033, USD (Million)
  • TABLE 75 Africa Post-operative Pain Therapeutics Market By Distribution Channel, 2023-2033, USD (Million)
  • TABLE 76 Rest of Middle East and Africa Post-operative Pain Therapeutics Market By Drug Class, 2023-2033, USD (Million)
  • TABLE 77 Rest of Middle East and Africa Post-operative Pain Therapeutics Market By Route of Administration, 2023-2033, USD (Million)
  • TABLE 78 Rest of Middle East and Africa Post-operative Pain Therapeutics Market By Distribution Channel, 2023-2033, USD (Million)

List of Figures

  • FIG. 1 Global Post-operative Pain Therapeutics Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Post-operative Pain Therapeutics Market: Quality Assurance
  • FIG. 5 Global Post-operative Pain Therapeutics Market, By Drug Class, 2024
  • FIG. 6 Global Post-operative Pain Therapeutics Market, By Route of Administration, 2024
  • FIG. 7 Global Post-operative Pain Therapeutics Market, By Distribution Channel, 2024
  • FIG. 8 Global Post-operative Pain Therapeutics Market, By Geography, 2024
  • FIG. 9 Market Geographical Opportunity Matrix - Global Post-operative Pain Therapeutics Market, 2024
  • FIG. 10 Market Positioning of Key Post-operative Pain Therapeutics Market Players, 2024
  • FIG. 11 Global Post-operative Pain Therapeutics Market, By Drug Class, 2024 Vs 2033, %
  • FIG. 12 Global Post-operative Pain Therapeutics Market, By Route of Administration, 2024 Vs 2033, %
  • FIG. 13 Global Post-operative Pain Therapeutics Market, By Distribution Channel, 2024 Vs 2033, %
  • FIG. 14 U.S. Post-operative Pain Therapeutics Market (US$ Million), 2023 - 2033
  • FIG. 15 Canada Post-operative Pain Therapeutics Market (US$ Million), 2023 - 2033
  • FIG. 16 Rest of North America Post-operative Pain Therapeutics Market (US$ Million), 2023 - 2033
  • FIG. 17 UK Post-operative Pain Therapeutics Market (US$ Million), 2023 - 2033
  • FIG. 18 Germany Post-operative Pain Therapeutics Market (US$ Million), 2023 - 2033
  • FIG. 19 Spain Post-operative Pain Therapeutics Market (US$ Million), 2023 - 2033
  • FIG. 20 Italy Post-operative Pain Therapeutics Market (US$ Million), 2023 - 2033
  • FIG. 21 France Post-operative Pain Therapeutics Market (US$ Million), 2023 - 2033
  • FIG. 22 Rest of Europe Post-operative Pain Therapeutics Market (US$ Million), 2023 - 2033
  • FIG. 23 China Post-operative Pain Therapeutics Market (US$ Million), 2023 - 2033
  • FIG. 24 Japan Post-operative Pain Therapeutics Market (US$ Million), 2023 - 2033
  • FIG. 25 India Post-operative Pain Therapeutics Market (US$ Million), 2023 - 2033
  • FIG. 26 Australia Post-operative Pain Therapeutics Market (US$ Million), 2023 - 2033
  • FIG. 27 South Korea Post-operative Pain Therapeutics Market (US$ Million), 2023 - 2033
  • FIG. 28 Rest of Asia Post-operative Pain Therapeutics Market (US$ Million), 2023 - 2033
  • FIG. 29 Brazil Post-operative Pain Therapeutics Market (US$ Million), 2023 - 2033
  • FIG. 30 Mexico Post-operative Pain Therapeutics Market (US$ Million), 2023 - 2033
  • FIG. 31 Rest of Latin America Post-operative Pain Therapeutics Market (US$ Million), 2023 - 2033
  • FIG. 32 GCC Post-operative Pain Therapeutics Market (US$ Million), 2023 - 2033
  • FIG. 33 Africa Post-operative Pain Therapeutics Market (US$ Million), 2023 - 2033
  • FIG. 34 Rest of Middle East and Africa Post-operative Pain Therapeutics Market (US$ Million), 2023 - 2033
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!